• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Use After Mass Shootings

November 7, 2018

Since 2000, mass shootings (>3 deaths) have increased in frequency and severity.  Hemorrhage is the main cause of death immediately following gun shoot wounds, and survival of these patients depends on stopping the bleeding using tourniquets and expedient transfusion of blood components.  Retrospective data collected after the October 2017 mass shooting in Las Vegas, Nevada, which killed 58 and injured more than 600, indicated that the available blood supply was adequate for the wounded patients.  After the Las Vegas shooting, almost 500 blood products were transfused to 220 hospitalized patients (68 in critical care) during the first 24 hours in a RBC: plasma: platelet ratio of 1:0.54:0.81.  United Blood Services (now Vitalant) and the American Red Cross provided Las Vegas hospitals an additional 700 blood products to replace units that had been used within the first 14 hours after the shooting.  Calls for donations from well-meaning agencies led to 791 blood donations immediately following the shooting of which 137 (17.3%) were wasted.  Maintaining adequate supplies of blood from routine donations and training in hemorrhage control may help communities prepare for future mass shootings.

Reference:

  1. Lozada MJ, Cai S, Li M, Davidson SL, Nix J, and G Ramsey. The Las Vegas mass shooting: an analysis of blood component administration and blood bank donations. Journal of Trauma and Acute Care Surgery 2018

Filed Under

  • Blood Donation
  • News

Recommended

  • Tranexamic Acid Does Not Reduce Bleeding or Transfusions in Patients with Hematological Malignancies

  • FDA Issues Emergency Use Authorization for SARS-CoV-2 Monoclonal Antibody Therapy

  • New Ebola Treatment Options Available

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley